Edition:
United Kingdom

People: Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

253.67USD
17 Sep 2018
Change (% chg)

-- (--)
Prev Close
$253.67
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
107,352
52-wk High
$261.14
52-wk Low
$126.77

Berkman, Charles 

Mr. Charles S. Berkman J.D. is Senior Vice President, General Counsel, Secretary of the Company. Mr. Berkman joined the Company in November 2001 and previously served as Associate General Counsel and Chief Patent Counsel for the Company (and Secretary since March 2007). Prior to joining the Company, Mr. Berkman was an attorney at the international law firm of Baker & McKenzie from November 2000 to November 2001. Before that he served as an attorney at the law firm of Lyon & Lyon from 1993 to November 2000, where he specialized in intellectual property law. Mr. Berkman earned a B.S. in chemistry from the University of Texas and a J.D. from the University of Texas School of Law.

Basic Compensation

Total Annual Compensation, USD 536,962
Restricted Stock Award, USD 466,461
Long-Term Incentive Plans, USD --
All Other, USD 495,396
Fiscal Year Total, USD 1,498,820

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 30,347 2,076,800.00
Name Fiscal Year Total

John Kozarich

291,078

Matthew Foehr

3,458,500

John Higgins

5,513,210

Matthew Korenberg

2,185,720

Charles Berkman

1,498,820

Jason Aryeh

277,156
As Of  31 Dec 2017